bpc-157 human clinical trials safety dosing Dosage Guide: Protocols & 2026 bpc-157 human clinical trials dosing

BPC-157, or Body Protecting Compound-157, is a 15-amino-acid peptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) isolated from gastric juices.[1][2] It was first identified in the 1990s as part of research into cytoprotective agents that safeguard the gastrointestinal (GI) tract from damage.[3] Unlike many peptides, BPC-157 is highly stable in acidic environments, allowing for oral administration without significant degradation.[4] In compounding pharmacies, BPC-157 is often prepared as capsules, injectables, or topical formulations

Semax & Selank appears in research contexts involving anxiolytic pathway research, neuropeptide models, immune-neural signaling studies

Dosing range: 250-500mcg subcutaneous once daily

Muscle tears

Oral BPC-157 capsules exist and have some utility for gut-specific indications because of localized activity in the GI tract

BPC-157 also stimulates the production of new blood vessels, which helps with healing, but also may create new blood supplies for tumors, helping them grow and spread